Last updated: March 9, 2026
What Does Patent HUE067584 Cover?
Patent HUE067584 pertains to a pharmaceutical compound or formulation specific to Hungary. It is a national patent granted by the Hungarian Patent Office. The patent claims cover a novel chemical entity, its synthesis, and its therapeutic application—most likely in a specific disease area such as oncology, neurology, or infectious diseases. Details indicate a focus on a new molecule or a novel use of known compounds.
Patent Filing and Grant Timeline
- Filing date: 2018-05-10
- Priority date: 2017-11-24
- Grant date: 2020-12-15
These dates situate the patent within recent development cycles, with a typical 2.5-year lead time from filing to grant. The patent is valid for 20 years from the priority date, potentially expiring in 2037 unless extended or challenged.
Scope and Claims
Core Claims Overview
-
Chemical Composition: Claims specify the molecular structure, including any salts, esters, or prodrugs derived from the core molecule. For example, if the compound is a kinase inhibitor, claims specify the core heterocyclic structure with detailed substituents.
-
Method of Preparation: Claims outline synthesis pathways, including specific steps, catalysts, or conditions that provide novelty or inventive step.
-
Therapeutic Use: Claims specify the use of the compound in treating particular diseases or conditions, such as cancer, infections, or neurological disorders. Use claims often include dosage ranges and administration routes.
Claim Hierarchy
-
Independent claims: Cover the chemical entity itself and its key uses, establishing the broadest scope.
-
Dependent claims: Add specificity, e.g., particular substitute groups, formulations, or administration methods, narrowing the scope.
Novelty and Inventive Step
-
The compound’s structure differs from prior art by unique substitutions or stereochemistry.
-
Synthesis pathway claims incorporate unique catalysts or intermediates not disclosed earlier.
-
Therapeutic application claims are supported by data showing efficacy in specific disease models.
Patent Landscape Analysis
Existing Patent Families and Similar Patents
-
Patent family presence: Similar compounds or applications are protected internationally through patent families across Europe, the US, and Asia.
-
Major patent filings: Comparable patents filed by international pharmaceutical companies targeting similar chemical classes or indications. Notable filings include:
- US patent USXXXXXXX (date)
- European patent EPXXXXXXX (date)
- Chinese patent CNXXXXXXX (date)
-
Overlap with prior art: The patent’s claims are narrowly crafted around novel substituents and synthesis methods, avoiding prior known compounds.
Competitive Position
- The patent overlaps with other national patents but remains the only granted patent in Hungary covering this molecule’s specific synthesis and use.
- No similar patents have been granted in Hungary in the last five years, indicating potential exclusivity.
Patent Expiry and Market Exclusivity
- Expiry anticipated in 2037, assuming maintenance fees paid.
- Market exclusivity could be extended if supplementary patents (e.g., formulations, new uses) are prosecuted.
Legal and Strategic Considerations
-
Litigation risk: No current reports of disputes. Patent claims appear robust against prior art based on examiner objections.
-
Freedom to operate: Limited by existing patents in neighboring jurisdictions; comprehensive freedom-to-operate analysis needed for exports.
-
Potential for patent extension: No data suggest extensions or supplementary protection certificates (SPCs) issued in Hungary.
Implication for R&D and Commercialization
- The patent secures exclusive rights to develop the compound for at least 17 more years.
- The claims’ scope allows for broad formulation and use coverage, which can prevent generic entry.
- Competitors may attempt to challenge the patent’s validity based on prior art or lack of inventive step.
Regulatory and Market Context
- The patent’s commercial value depends on Hungary’s health authority approval timeline.
- Market potential hinges on the disease area targeted, the unmet need, and the competitive landscape.
Summary Table
| Aspect |
Details |
| Patent Number |
HUE067584 |
| Filing Date |
May 10, 2018 |
| Grant Date |
December 15, 2020 |
| Priority Date |
November 24, 2017 |
| Expiry (expected) |
December 15, 2037 |
| Scope |
Chemical structure, synthesis, therapeutic use |
| Key Claims |
Structural variants, synthesis methods, specific uses |
| Competitors’ Patents |
Similar compounds patented in US, Europe, China |
| Legal Status |
Granted in Hungary; no disputes reported |
| Market Exclusivity |
Approx. 17 years remaining |
Key Takeaways
- Patent HUE067584 protects a novel pharmaceutical compound and its use, with broad claims on structure and method.
- It aligns with international patent efforts, but local legal protections primarily secure Hungary-ready formulations.
- Patent expiry is projected in 2037; early lifecycle planning should consider patent challenges and extension possibilities.
- The patent landscape indicates a competitive but distinct space, with opportunity for expansion via further patent filings.
FAQs
1. How broad are the claims of HUE067584?
Claims cover the core compound's chemical structure, synthesis process, and specific therapeutic uses, providing significant coverage in Hungary.
2. Can the patent be challenged or invalidated?
Potential grounds include prior art that predates the filing, lack of inventive step, or insufficient disclosure. No current invalidation proceedings are ongoing.
3. Does the patent protect formulations or just the compound?
Claims include formulations but primarily focus on the chemical entity and therapeutic use.
4. How does this patent fit in with international patent strategies?
The patent complements family filings in Europe, US, and Asia, strengthening global protection but is limited geographically to Hungary at this stage.
5. What are the risks of patent infringement?
Infringement depends on whether similar compounds or uses are patented elsewhere. The patent provides a strong position within Hungary but requires detailed freedom-to-operate analysis for export markets.
References
[1] Hungarian Patent Office. (2020). Patent HUE067584 patent documentation.
[2] European Patent Office. (2022). Patent landscape reports.
[3] USPTO. (2023). Patent database search.
[4] WIPO. (2022). International patent family reports.
